Celladon
La Jolla
About Celladon
Celladon Corporation, a biotechnology company, develops and manufactures molecular therapies for the treatment of heart failure. Its products include SERCA2a, an enzyme that regulates calcium cycling and contractility in heart muscle cells; and MYDICAR, an enzyme replacement therapy for heart failure. Celladon was founded in 2000 and is based in La Jolla, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $152.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Nov 2015)
- Ticker: nasdaq:CLDN
- Website: celladon.net
- Phone: (858) 366-4288
Industries & Categories
Biotechnology, Health Care, Hospital, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/celladon-549644 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.